The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Key takeaways
- Medtronic PLC is a medical devices business with stocks listed in the US on the NYSE.
- To buy shares you'll need a trading platform that allows you to buy in the US. You should compare foreign exchange and other trading fees.
- You can track Medtronic’s dividend yield and P/E ratio regularly to decide if it aligns with your income or growth investing goals.
Medtronic PLC (MDT) is a leading medical devices business with stocks listed in the US. It closed the previous market day at US$101.97. During the previous open market day, the price has varied from a low of USD101.58 to a high of USD102.91. Medtronic is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in Medtronic
- Compare share trading platforms. To buy shares in a company listed in the US from Australia you'll need to find a trading platform that offers access to US stock markets. Look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, which will typically include your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Medtronic. Find the share by name or ticker symbol: MDT. Research its history to confirm it's a solid investment that matches your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Medtronic reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying using consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$101.97, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Medtronic, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Medtronic. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights.
Compare trading platforms to buy Medtronic shares
Compare other products
We currently don't have that product, but here are others to consider:
How we picked theseFinder Score for share trading platforms
We've scored over 30 share trading platforms assessing them for their core features, fees, customer experience and accessibility. Our experts give each platform a score out of 10.
Have Medtronic's shares ever split?
Medtronic's shares were split on a 2:1 basis on 26 September 1999. So if you had owned 1 share the day before the split, the next day you would own 2 shares. This wouldn't directly have changed the overall worth of your Medtronic shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Medtronic shares which in turn could have impacted Medtronic's share price.
Medtronic shares at a glance
Information last updated 2025-12-02.
| 52-week range | US$76.9892 - US$106.33 |
|---|---|
| 50-day moving average | US$96.1794 |
| 200-day moving average | US$90.5608 |
| Target price | US$110.3154 |
| PE ratio | 27.6504 |
| Dividend yield | US$2.82 (2.73%) |
| Earnings per share (TTM) | US$3.69 |
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Medtronic price performance over time
Historical closes compared with the last close of $101.97
| 1 week (2025-11-26) | -2.90% |
|---|---|
| 1 month (2025-11-04) | 12.77% |
| 3 months (2025-09-04) | 9.82% |
| 6 months (2025-06-04) | 19.12% |
| 1 year (2024-12-04) | 19.51% |
|---|---|
| 2 years (2023-12-04) | 27.85% |
| 3 years (2022-12-02) | 28.07% |
| 5 years (2020-12-04) | -10.43% |
Is it a good time to buy Medtronic stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is it worth buying Medtronic stock?
Valuing Medtronic stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medtronic's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medtronic's P/E ratio
Medtronic's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, Medtronic shares trade at around 28x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
Medtronic's PEG ratio
Medtronic's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.9207. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medtronic's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Medtronic's EBITDA
Medtronic's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$9.6 billion (£7.2 billion).
The EBITDA is a measure of a Medtronic's overall financial performance and is widely used to measure stock profitability.
Medtronic share price volatility
Over the last 12 months, Medtronic's shares have ranged in value from as little as US$76.9892 up to US$106.33. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Medtronic's is 0.739. This would suggest that Medtronic's shares are less volatile than average (for this exchange).
Medtronic financials
| Revenue TTM | US$34.8 billion |
|---|---|
| Operating margin TTM | 20.3% |
| Gross profit TTM | US$22.8 billion |
| Return on assets TTM | 4.69% |
| Return on equity TTM | 9.82% |
| Profit margin | 13.71% |
| Book value | 37.951 |
| Market capitalisation | US$130.9 billion |
| EBITDA | US$9.6 billion |
TTM: trailing 12 months
Medtronic share dividends
Dividend payout ratio: 50.09% of net profits
Recently Medtronic has paid out, on average, around 50.09% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.75% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medtronic shareholders could enjoy a 2.75% return on their shares, in the form of dividend payments. In Medtronic's case, that would currently equate to about $2.82 per share.
Medtronic's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Medtronic's most recent dividend payout was on 16 October 2025. The latest dividend was paid out to all shareholders who bought their shares by 25 September 2025 (the "ex-dividend date").
Medtronic's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Medtronic.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Medtronic's total ESG risk score
Total ESG risk: 26.86
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Medtronic's overall score of 26.86 (as at 12/31/2018) is nothing to write home about – landing it in it in the 41st percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Medtronic is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Medtronic's environmental score
Environmental score: 4.07/100
Medtronic's environmental score of 4.07 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Medtronic is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Medtronic's social score
Social score: 15.28/100
Medtronic's social score of 15.28 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Medtronic is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Medtronic's governance score
Governance score: 9/100
Medtronic's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Medtronic is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Medtronic's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Medtronic scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Medtronic hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Medtronic PLC was last rated for ESG on: 2019-01-01.
| Total ESG score | 26.86 |
|---|---|
| Total ESG percentile | 40.62 |
| Environmental score | 4.07 |
| Environmental score percentile | 5 |
| Social score | 15.28 |
| Social score percentile | 5 |
| Governance score | 9 |
| Governance score percentile | 5 |
| Level of controversy | 3 |
Medtronic overview
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Frequently asked questions
Sources
More resources on Finder
Ask a question
More guides on Finder
-
Best short term investments in Australia for 2025
If you have funds to invest for 2 or years or less, you can safely earn up to 5% p.a. through a high interest savings account, bonds or ETFs.
-
How to buy Washington H. Soul Pattinson and Company shares in Australia
Steps to owning and managing Washington H. Soul Pattinson and Company shares from in Australia.
-
How to invest in copper in Australia
Copper is an industrial metal with many applications. Here’s what you should consider before investing.
-
How to invest in financial stocks in Australia
Financial stocks drive the economy and affect many aspects of a consumer’s economic life.
-
How to buy Viva Energy shares in Australia
Steps to owning and managing Viva Energy shares from in Australia.
-
How to buy Verizon shares in Australia
Steps to owning and managing Verizon shares from in Australia.
-
How to buy Wells Fargo shares in Australia
Steps to owning and managing Wells Fargo shares from in Australia.
-
How to buy Visa shares in Australia
Steps to owning and managing Visa shares from in Australia.
-
How to invest in cannabis stocks
Just 5 years ago, few investors took cannabis stocks seriously; today, as billions of dollars pour into the sector, few doubt that it will be one of the next big disruptors.
-
How to buy Uber shares in Australia
Steps to owning and managing Uber shares from in Australia.